Prof. Michael J. Cima, Ph.D.
David H. Koch Professor of Engineering
Faculty Director of the Lemelson-MIT Program
Associate Dean for Innovation
Department of Materials Science and Engineering
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology (MIT)
Medical Product Development is at the center of turning a hypothesis into a product that is valuable to patients, physicians, and the entire healthcare system. Scientific and medical insight is often the starting point in the conception of a product, but it is far from sufficient. Development should not be confused with product design. There is no doubt that extensive conversations with users are an integral session of development just as in design. Development, however, includes a much broader range of activities that prove the benefit of the product and ensure that it is safe and reliable. Experience with all aspects of development has a profound influence on the first steps taken in conceiving a product. That experience can even influence the conduct of the earliest basic research. What unmet need should I pursue? What difficulties can I foresee encountering during development? How will I prove that the potential product is effective and safe? Can such a product be reimbursed if developed? This talk will introduce you to how to think strategically at the beginning of your medical product adventure. Finally, many courses on development focus on drugs or devices. I have worked on both and am struck by the similarities. Thus, this talk will discuss both. The same principles apply to the development of each, while the details are different.
Professor Cima’s Bio:
Michael is the David H. Koch Professor of Engineering and a Professor of Materials Science and Engineering at the Massachusetts Institute of Technology. He also is an investigator at the David H. Koch Institute for Integrative Cancer Research. He has a B.S. in chemistry and a Ph.D. in chemical engineering from the University of California at Berkeley. He is the faculty director of the Lemelson-MIT Program, a U.S.-based program aimed at inspiring youth to be inventive. Michael is also co-director of MIT’s Innovation Initiative and the Associate Dean of Innovation for the School of Engineering Prof. Cima is author or co-author of over three hundred peer reviewed scientific publications, fifty US patents, and is a recognized expert in the field of medical devices and materials processing. He is a coinventor of MIT’s three-dimensional printing process. Machines and products by many licensees based on this process are used throughout the world. He and collaborators are developing implantable MEMS devices for unprecedented control in the delivery of pharmaceuticals and implantable diagnostic systems. Finally, through his consulting work he has been a major contributor to the development of high throughput systems for discovery of novel crystal forms and formulations of pharmaceuticals. Prof. Cima also has extensive entrepreneurial experience. He is co-founder and director of MicroChips Biotech., a developer of microelectronic based drug delivery and diagnostic systems. Prof. Cima took two sabbaticals to act as senior consultant and management team member at Transform Pharmaceuticals Inc. a company that he helped start and that was ultimately acquired by Johnson and Johnson Corporation. He is a co-founder at T2 Biosystems a medical diagnostics company. Prof. Cima is also a co-founder of Taris Biomedical a company recently acquired by Johnson and Johnson which specializes in pharmaceutical products for urology.
WHEN: Friday, March 12, from 4-5:30 p.m.
-Submitted by Fayez Safadi